Abstract
Fragmentation in behavioral and mental health care to children has resulted in suboptimal care and high rates of psychotropic medication use, especially antipsychotic medications (APM). A qualitative study, based on the Theory of Planned Behavior (TPB), aimed to better understand prescribing practices, barriers to optimal treatment, and potential interventions to safeguard the use of APM for children in Kentucky. The most common barrier to optimal care was access to mental health specialists. Social norms and pressure from families contribute to increased medication use. We identify promising interventions to safeguard the use of APM through the lens of the TPB.
Similar content being viewed by others
References
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Decision Making Processes, 50, 179–211.
Almandil, N. B., Liu, Y., Murray, M. L., Besag, F. M., Aitchison, K. J., & Wong, I. C. (2013). Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: A systematic review and meta-analysis. Paediatric Drugs, 15(2), 139–150.
American Academy of Child & Adolescent Psychiatry. (2009). Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 48(9), 961–973. doi:10.1097/CHI.0b013e3181ae0a08.
American Psychiatric Association. (2013). Choosing wisely: Five things physicians and patients should question Retrieved December 4, 2015, from http://www.choosingwisely.org/societies/american-psychiatric-association/.
Arango, C., Giraldez, M., Merchan-Naranjo, J., Baeza, I., Castro-Fornieles, J., Alda, J. A., et al. (2014). Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naive patients. Journal of the American Academy of Child & Adolescent Psychiatry, 53(11), 1179–1190. doi:10.1016/j.jaac.2014.08.009.
Becker, E. R., Constantine, R. J., McPherson, M. A., & Jones, M. E. (2013). Antipsychotic polypharmacy prescribing patterns and costs in the Florida adult and child Medicaid populations. Journal of Health Care Finance, 40(1), 40–67.
Bobo, W. V., Cooper, W. O., Stein, C. M., Olfson, M., Graham, D., Daugherty, J., et al. (2013). Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry, 70(10), 1067–1075.
Carbon, M., Kapoor, S., Sheridan, E., Al-Jadiri, A., Azzo, S., Sarkaria, T., et al. (2015). Neuromotor adverse effects in 342 youth during 12 weeks of naturalistic treatment with 5 s-generation antipsychotics. Journal of the American Academy of Child & Adolescent Psychiatry, 54(9), 718–727. doi:10.1016/j.jaac.2015.06.015.
Carpenter-Song, E., & Snell-Rood, C. (2016). The changing context of rural America: A call to examine the impact of social change on mental health and mental health care. Psychiatric Services, appips201600024. doi:10.1176/appi.ps.201600024.
Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA: The Journal of the American Medical Association, 302(16), 1765–1773. doi:10.1001/jama.2009.1549.
Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Affairs, 28(5), w770–w781. doi:10.1377/hlthaff.28.5.w770.
Davis, D. W., Smith, M. J., Feygin, Y., Myers, J., Lohr, D., Collins-Camargo, C., Williams, P. G., Jones, V. F. (2016). Medication prescribing to children insured by Kentucky Medicaid interim report December 2016. Unpublished data analysis. Pediatrics. University of Louisville. Louisville, KY.
De Hert, M., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011). Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry, 26(3), 144–158. doi:10.1016/j.eurpsy.2010.09.011.
dosReis, S., Yoon, Y., Rubin, D. M., Riddle, M. A., Noll, E., & Rothbard, A. (2011). Antipsychotic treatment among youth in foster care. Pediatrics, 128(6), e1459–e1466. doi:10.1542/peds.2010-2970.
Fairbrother, G. L., Emerson, H. P., & Partridge, L. (2007). How stable is medicaid coverage for children? Health Affairs, 26(2), 520–528. doi:10.1377/hlthaff.26.2.520.
Findling, R., Drury, S., Jensen, P., & Rappaport, J. (2011). Practice parameter for the use of atypical antipsychotic medications in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP). Washington, D.C.
Fraguas, D., Correll, C. U., Merchan-Naranjo, J., Rapado-Castro, M., Parellada, M., Moreno, C., et al. (2011). Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons. European Neuropsychopharmacology, 21(8), 621–645. doi:10.1016/j.euroneuro.2010.07.002.
Friedman, R. M., & Kutash, K. (1992). Challenges for child and adolescent mental health. Health Affairs, 11(3), 125–136.
Hilt, R. J., Romaire, M. A., McDonell, M. G., Sears, J. M., Krupski, A., Thompson, J. N., et al. (2013). The partnership access line: Evaluating a child psychiatry consult program in Washington State. JAMA Pediatrics, 167(2), 162–168.
Hilt, R. J., Barclay, R. P., Bush, J., Stout, B., Anderson, N., & Wignall, J. R. (2015). A statewide child telepsychiatry consult system yields desired health system changes and savings. Telemedicine Journal and E-health: The Official Journal of the American Telemedicine Association, 21(7), 533–537. doi:10.1089/tmj.2014.0161.
Hogan, M. F. (2003). The President’s New Freedom Commission: Recommendations to transform mental health care in America. Psychiatric Services, 54(11), 1467–1474. doi:10.1176/appi.ps.54.11.1467.
Howie, L. D., Pastor, P. N., & Lukacs, S. L. (2014). Use of medication prescribed for emotional or behavioral difficulties among children aged 6–17 years in the United States, 2011–2012: NCHS data brief. Hyattsville, MD: National Center for Health Statistics.
Knapp, P., Chait, A., Pappadopulos, E., Crystal, S., & Jensen, P. S. (2012). Treatment of maladaptive aggression in youth: CERT guidelines I. Engagement, assessment, and management. Pediatrics, 129(6), e1562–e1576. doi:10.1542/peds.2010-1360.
Lohr, W. D., Chowning, R. T., Stevenson, M. D., & Williams, P. G. (2015). Trends in atypical antipsychotics prescribed to children six years of age or less on Medicaid in Kentucky. Journal of Child and Adolescent Psychopharmacology, 25(5), 440–443. doi:10.1089/cap.2014.0057.
Medco Health Solutions. (2011). America’s state of mind Retrieved February 1, 2017, from http://apps.who.int/medicinedocs/documents/s19032en/s19032en.pdf.
Morrato, E. H., Nicol, G. E., Maahs, D., Druss, B. G., Hartung, D. M., Valuck, R. J., et al. (2010). Metabolic screening in children receiving antipsychotic drug treatment. Archives of Pediatric and Adolescent Medicine, 164(4), 344–351. doi:10.1001/archpediatrics.2010.48.
Murphy, A. L., Gardner, D. M., Kisely, S., Cooke, C. A., Kutcher, S. P., & Hughes, J. (2015). System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescents. Clinical Child Psychology and Psychiatry. doi:10.1177/1359104515617518.
Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child & Adolescent Psychiatry, 49(1), 13–23.
Olfson, M., Blanco, C., Liu, S. M., Wang, S., & Correll, C. U. (2012). National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Archives of General Psychiatry, 69(12), 1247–1256. doi:10.1001/archgenpsychiatry.2012.647.
Olfson, M., Blanco, C., Wang, S., Laje, G., & Correll, C. U. (2014). National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry, 71(1), 81–90. doi:10.1001/jamapsychiatry.2013.3074.
Pidano, A. E., & Honigfeld, L. (2012). Pediatric psychopharmacology: Context, model programs, and considerations for care. Psychiatric Services, 63(9), 929–934. doi:10.1176/appi.ps.201100318.
Pope, C., & Mays, N. (2006). Qualitative research in health care. Malden, MA: Blackwell.
Rosato, N. S., Correll, C. U., Pappadopulos, E., Chait, A., Crystal, S., & Jensen, P. S. (2012). Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management. Pediatrics, 129(6), e1577–e1586. doi:10.1542/peds.2010-1361.
Rubin, D. M., Kreider, A. R., Matone, M., Huang, Y. S., Feudtner, C., Ross, M. E., et al. (2015). Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths. JAMA Pediatrics, 169(4), e150285. doi:10.1001/jamapediatrics.2015.0285.
Sarvet, B., Gold, J., Bostic, J. Q., Masek, B. J., Prince, J. B., Jeffers-Terry, M., et al. (2010). Improving access to mental health care for children: The Massachusetts Child Psychiatry Access Project. Pediatrics, 126(6), 1191–1200.
Seabury, S. A., Goldman, D. P., Kalsekar, I., Sheehan, J. J., Laubmeier, K., & Lakdawalla, D. N. (2014). Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. American Journal of Managed Care, 20(2), e52–e60.
Thomas, K. C., Ellis, A. R., Konrad, T. R., Holzer, C. E., & Morrissey, J. P. (2009). County-level estimates of mental health professional shortage in the United States. Psychiatric Services, 60(10), 1323–1328. doi:10.1176/ps.2009.60.10.1323.
U.S. Department of Health and Human Services. (2013). The U.S. Health Workforce Chartbook Part 4: Behavioral and allied health. Rockville, MD: Health Resources and Services Administration (HRSA) and National Center for Health Workforce Analysis.
Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56(2), 157–163. doi:10.1176/appi.ps.56.2.157.
Funding
The study was funded, in part, by a grant from Passport Health Plans, Louisville, Kentucky and from the Kentucky Cabinet for Health & Family Services, Department of Medicaid Services. The authors wish to thank the providers and their office staff for their participation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have any conflicts of interest or disclosures to report.
Rights and permissions
About this article
Cite this article
Lohr, W.D., Brothers, K.B., Davis, D.W. et al. Providers’ Behaviors and Beliefs on Prescribing Antipsychotic Medication to Children: A Qualitative Study. Community Ment Health J 54, 17–26 (2018). https://doi.org/10.1007/s10597-017-0125-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-017-0125-8